Literature DB >> 2942414

Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats.

T Yamada, K Nakao, N Morii, H Itoh, S Shiono, M Sakamoto, A Sugawara, Y Saito, H Ohno, A Kanai.   

Abstract

The effect of intracerebroventricular (i.c.v.) treatment of alpha-human atrial natriuretic polypeptide on the vasopressin secretion induced by i.c.v. injection of angiotensin II was studied in conscious, unrestrained rats. Pretreatment of alpha-human atrial natriuretic polypeptide (5 micrograms) significantly inhibited the angiotensin II (100 ng)-stimulated vasopressin secretion. This result suggests that atrial natriuretic polypeptide plays regulatory roles in vasopressin secretion in the central nervous system.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2942414     DOI： 10.1016/0014-2999(86)90802-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


  10 in total

1.  Intracerebroventricular administration of atrial natriuretic peptide prevents increase of plasma ADH, aldosterone and corticosterone levels in restrained conscious dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; S Bountzioukas; K Mavroudis; M Karamouzis; O Guiba-Tziampiri
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

2.  Effects of intracerebroventricular administration of atrial natriuretic peptide (ANP) on blood pressure, heart rate and plasma ADH and corticosterone levels in normal and dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; M Apostolakis; S Bountzioukas; O Guiba-Tziampiri; H Kontoleon-Vakalopoulou; K Mavroudis
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

3.  Impact of acute and chronic sodium loading on atrial natriuretic peptide and renin in man.

Authors:  G Wambach; M Stimpel; G Bönner; S Degenhardt; W Kaufmann
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

4.  Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-C-mediated brain-to-blood efflux transport at the blood-brain barrier.

Authors:  Shingo Ito; Sumio Ohtsuki; Yuki Katsukura; Miho Funaki; Yusuke Koitabashi; Akihiko Sugino; Sho Murata; Tetsuya Terasaki
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

Review 5.  [Atrial natriuretic peptide and its significance for arterial hypertension].

Authors:  G Wambach; M Stimpel; G Bönner
Journal:  Klin Wochenschr       Date:  1989-11-03

6.  Evidence for a dopaminergic mechanism for the diuretic and natriuretic action of centrally administered atrial natriuretic factor.

Authors:  A Israel; M Torres; Y Barbella
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

7.  The renal and vascular effects of central angiotensin II and atrial natriuretic factor in the anaesthetized rat.

Authors:  K A Al-Barazanji; R J Balment
Journal:  J Physiol       Date:  1990-04       Impact factor: 5.182

Review 8.  Interactions between atrial natriuretic factor and the autonomic nervous system.

Authors:  C C Lang; A D Struthers
Journal:  Clin Auton Res       Date:  1991-12       Impact factor: 4.435

Review 9.  Translational research of novel hormones: lessons from animal models and rare human diseases for common human diseases.

Authors:  Kazuwa Nakao; Akihiro Yasoda; Ken Ebihara; Kiminori Hosoda; Masashi Mukoyama
Journal:  J Mol Med (Berl)       Date:  2009-10       Impact factor: 4.599

Review 10.  Translational science: Newly emerging science in biology and medicine - Lessons from translational research on the natriuretic peptide family and leptin.

Authors:  Kazuwa Nakao
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2019       Impact factor: 3.493
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.